COVID-19: Read our latest information here.

News and Views

RNS Number : 3624U
W.H. Ireland Group PLC
28 July 2020
 

 

 

WH Ireland Group Plc

 

(“WH Ireland” or the “Company”)

 

Additional participation in NED Scheme

Following the issue of the NED Scheme Shares on 23 July 2020, the Company is pleased to confirm that Alistair Buchanan, as the newest Non-Executive Director of the Company has today agreed to receive ordinary shares in the Company in lieu of 25 per cent of the fees (being a total of £5k) that would otherwise be due to be paid to him by the Company in respect of the six month period commencing on 1 June 2020 and ending on 30 November 2020. The number of ordinary shares will be determined on the basis of the volume weighted average of the middle market quotations for one ordinary share for the 30 consecutive trading days ending on 30 November 2020.

In accordance with the agreement with Polygon Global Partners LLP (“Polygon”), announced on 17 October 2017, Polygon has consented to this arrangement.

A further announcement will be made when the relevant shares are issued.

For further information please contact:

WH Ireland Group plc                                                                                             www.whirelandplc.com

Phillip Wale, Chief Executive Officer                                                                     +44(0) 20 7220 1666           

 

SPARK Advisory Partners Limited (Nominated Adviser)

Andrew Emmott                                                                                                       +44(0) 20 3368 3555           

 

MHP Communications                                                                                                        +44 (0) 20 3128 8793

Reg Hoare / James Bavister                                                                                                whireland@mhpc.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 

END

 
 

MSCBBGDRXUDDGGI